Search Login Register

mofezolac (N 22) Summary

2955 relevant articles (41 outcomes, 278 trials/studies) found for this Bio-Agent

Description: cyclooxygenase-1 selective inhibitor; structure given in first source; RN from Toxlit

Also Known As: N 22; (3,4-bis(4-methoxyphenyl)-5-isoxazolyl)acetic acid; (3,4-di-(4-methoxyphenyl)-5-isoxazolyl)acetic acid; 3,4-DMPIAA; N-22

Key Diseases for which mofezolac is Relevant

  1. Infection : 4 outcomes 15 studies in 92 results
  2. Neoplasms (Cancer) : 4 outcomes 13 studies in 224 results
  3. Hypertension (High Blood Pressure) : 3 outcomes 10 studies in 62 results
  4. Breast Neoplasms (Breast Cancer) : 3 outcomes 5 studies in 38 results
  5. Carcinoma (Carcinomatosis) : 2 outcomes 9 studies in 87 results
Show All >>

Drugs Related to mofezolac

  1. tranilast (N 5')
  2. N 30
  3. Cyclophosphamide (Cytoxan)
  4. quetiapine (Seroquel)
  5. Interferons
  6. Ethanol (Ethyl Alcohol)
  7. Methotrexate (Mexate)
  8. Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)
  9. HLA-DR Antigens (HLA-DR)
  10. Steroids
Show All >>

Therapies Related to mofezolac

  1. Drug Therapy (Chemotherapy)
  2. Transplants (Transplant)
  3. Percutaneous Coronary Transluminal Angioplasty (PTCA)
  4. Stem Cell Transplantation
  5. Combination Drug Therapy (Combination Chemotherapy)
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2008 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.